Hans J. W. de Haard founded argenx SE and AgomAb Therapeutics NV. Currently, he holds the position of Chief Scientific Officer at argenx SE. He is also Professor at Université de Franche-Comté and Professor-Camelid Immunology at the University of Utrecht.
He previously was Scientist at Unilever NV and Director-Technology Development at Ablynx NV.
Dr. De Haard received a doctorate and a graduate degree from Maastricht University.